Guest Editorials - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Guest Editorials

Bureaucratic Roadblocks Threaten Biopharma Growth

June 2, 2014

Pharmaceutical Technology

Protecting intellectual property rights is vital to biopharmaceutical innovation.

INTERPHEX 2014: New Partners, New Programs

March 2, 2014

Pharmaceutical Technology

Conference sessions from PDA and PharmTech expand educational opportunities at INTERPHEX 2014.

GDUFA Off to Good Start, But Storm Clouds on the Horizon

December 9, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

GDUFA is off to a good start from a facility inspection perspective, but there are storm clouds on the horizon.

Inspiring the Next Generation

December 2, 2013

Pharmaceutical Technology

Scientists can share time and pharmaceutical knowledge with high school students.

Changing the Dynamic of CROs

October 2, 2013

Pharmaceutical Technology

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Connecting People, Science, and Regulation

September 2, 2013

Pharmaceutical Technology

PDA/FDA regulatory conference promotes a commitment to quality.

INTERPHEX 2013: Aligning with Industry's Needs

April 2, 2013
Pharmaceutical Technology

Conference and exhibits provide a meeting place for professionals to exchange ideas.

Prescribing Caution for Biosimilars

April 2, 2013

Pharmaceutical Technology

Sound policies are needed to govern the substitution of interchangeable biologics.

Partnerships Remain Crucial to Future Development

October 2, 2012

Pharmaceutical Technology

Working together affords many unseen opportunities for pharmaceutical innovation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Click here